NeoGenomics Inc (NEO) — Capital Reinvestment Ratio
Latest as of December 2025:
5.86x
NeoGenomics Inc (NEO) has a Capital Reinvestment Ratio of 5.86x as of December 2025, meaning it reinvests 6% of its operating cash flow ($1.34 Million) in capital expenditures ($7.87 Million). See NeoGenomics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
5.86x
Capex / Operating Cash Flow
Operating Cash Flow
$1.34 Million
USD
Capital Expenditures
$7.87 Million
USD
Data as of
Dec 2025
Most recent filing
NeoGenomics Inc Capital Reinvestment Ratio (2011–2025)
This chart tracks NeoGenomics Inc's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for NeoGenomics Inc (2011–2025)
Year-by-year Capital Reinvestment Ratio for NeoGenomics Inc from 2011 to 2025. For live market cap and broader valuation context, see NEO market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.16x | $5.23 Million | $27.01 Million | ▼ -11.7% |
| 2024 | 5.85x | $7.02 Million | $41.06 Million | ▼ -70.7% |
| 2020 | 19.93x | $1.46 Million | $29.10 Million | ▲ +2225.2% |
| 2019 | 0.86x | $23.37 Million | $20.03 Million | ▲ +168.2% |
| 2018 | 0.32x | $44.79 Million | $14.31 Million | ▼ -57.9% |
| 2017 | 0.76x | $18.04 Million | $13.69 Million | ▲ +116.3% |
| 2016 | 0.35x | $21.48 Million | $7.54 Million | ▲ +1.3% |
| 2015 | 0.35x | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $69.00K | $897.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow